Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8650953 | American Heart Journal | 2018 | 30 Pages |
Abstract
In this registry of AF patients, older patients at elevated stroke and low bleeding risk were commonly treated with OAC. However, a variety of factors were associated with OAC non-prescription. Specifically, antiplatelet use was prevalent and associated with the highest likelihood of OAC non-prescription. Future studies are warranted to understand provider and patient rationale that may underlie observed associations with OAC non-prescription.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Steven A. MD, MPH, Shaan MD, Lu-Chen PhD, Gheorghe PhD, Joseph Walker MD, Qi MS, Anil K. MD, Jonathan C. MD, MAS, Matthew R. MD, MSc, Mintu P. MD, MAS, Thomas M. MD, MSc,